CB
Christine Bellon
Chief Legal Officer

Christine Bellon insider trades: Beam Therapeutics (BEAM) stock sales

Chief Legal Officer, Beam Therapeutics Last trade Apr 1, 2026 20 Form 4 filings
$825K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christine reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 1, 2026BEAM↓ Sell$146K
Jan 15, 2026BEAM↓ Sell$645K
Dec 31, 2025BEAM↓ Sell$34K
Oct 1, 2025BEAM↓ Sell$9K
Apr 1, 2025BEAM↓ Sell$104K
Feb 14, 2025BEAM↓ Sell$340K
Jan 2, 2025BEAM↓ Sell$31K
Oct 1, 2024BEAM↓ Sell$9K
Apr 1, 2024BEAM↓ Sell$109K
Jan 3, 2024BEAM↓ Sell$50K
Nov 20, 2023BEAM↓ Sell$305K
Oct 2, 2023BEAM↓ Sell$9K
Apr 4, 2023BEAM↓ Sell$62K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BEAM insiders

Open-market trades in the last 12 months

About Christine Bellon's insider trades

Christine Bellon is Chief Legal Officer at Beam Therapeutics (BEAM). Since Apr 4, 2023, Christine has reported no open-market purchases and 13 sales worth $1.9M on SEC Form 4. In the last 12 months: 3 sales ($825K).

Their filings also include grants and awards (7 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BEAM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.